• Home>
  • Stocks>
  • Procter & Gamble Health Ltd Share Price
Procter & Gamble Health Ltd share price logo

Procter & Gamble Health Ltd Share Price

NSE: PGHL

BSE: 500126

Small Cap

Healthcare Sector

6370.00

71.50 (1.14%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Procter & Gamble Health Ltd Stock Performance

as on August 29, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹6,252.5
    ₹6,739
    downward going graph

    1.84%

    Downside

    5.79%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹4,863
    ₹6,739
    downward going graph

    23.66%

    Downside

    5.79%

    Upside

    downward going graph

Procter & Gamble Health Ltd share price movements today

Previous Close
₹6,298.50
Open
₹6,606.00
Volume
67.16K
Upper Circuit
₹7,558.00
Lower Circuit
₹5,039.00
Day's Low - High
₹6,252.5 - ₹6,739
52 Week Low - High
₹4,863 - ₹6,739

Procter & Gamble Health Ltd Historical Returns

1 Month Return
+ 7.11 %
3 Month Return
+ 10.82 %
1 Year Return
+ 22.08 %
3 Year Return
+ 51.38 %
5 Year Return
+ 32.79 %

Procter & Gamble Health Ltd Fundamentals

as on August 29, 2025 at 4:01 pm IST

Market Cap

₹10,573.81 Cr

Return on Equity (ROE)

32.74

PE Ratio (TTM)

0

Return on capital employed (ROCE)

40.23

Beta (LTM)

0.41

P/B Ratio

15.9

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

294.4

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Procter & Gamble Health Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Procter & Gamble Health Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA10,573.816.56%0.00234934
BUY33,688.8635.52%0.522641,197
BUY16,297.9810.1%0.718367,234
NA4,546.22-4.46%1.88-34371
BUY15,255.2046.73%0.672441,515

Procter & Gamble Health Ltd Stock's Interest Amongst Investors

Search interest for Procter & Gamble Health Ltd Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:47% versus previous 30 day period

Procter & Gamble Health Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
297.55
309.97
320.92
301.18
304.93
309.97
252.48
283.88
313.41
309.77
310.99
338.74
Other Income
3.42
4.54
4.97
5.46
6.05
5.18
2.27
2.13
3.28
3.96
3.11
4.03
Total Income
300.97
314.51
325.89
306.64
310.98
315.15
254.75
286.01
316.69
313.73
314.1
342.77
Expenses
206.73
201.11
241.26
255.84
216.27
208.32
185.04
255.82
199.37
186.34
230.07
248.4
Operating Profit
90.82
108.86
79.66
45.34
88.66
101.65
67.44
28.06
114.04
123.43
80.92
90.34
Operating Profit Margin %
30.52%
35.12%
24.82%
15.05%
29.08%
32.79%
26.71%
9.88%
36.39%
39.85%
26.02%
26.67%
Profit Before Interest, Tax and Depreciation
94.24
113.4
84.63
50.8
94.71
106.83
69.71
30.19
117.32
127.39
84.03
94.37
Interest
0.16
0.23
0.21
0.17
0.18
0.19
0.15
0.2
0.15
0.15
0.13
0.12
Depreciation
7.48
8.23
5.89
6.5
6.48
6.92
6.84
7.16
5.77
5.55
5.37
5.44
Profit Before Tax
86.6
104.94
78.53
44.13
88.05
99.72
62.72
22.83
111.4
121.69
78.53
88.81
Tax Paid
22.94
28.14
19.34
14.31
22.48
27.65
16.16
6.05
29.07
30.79
17.35
22.63
Profit After Tax
63.66
76.8
59.19
29.82
65.57
72.07
46.56
16.78
82.33
90.9
61.18
66.18
Total Net profit including share of profit / Loss from associate company
63.66
76.8
59.19
29.82
65.57
72.07
46.56
16.78
82.33
90.9
61.18
66.18
EPS
38.3
46.3
35.66
17.96
39.5
43.4
28
9.5
49.6
54.76
36.86
39.87
Actual EPS
38.3
46.3
35.66
17.96
39.5
43.4
28
9.5
49.6
54.76
36.86
39.87
Adjusted EPS
38.3
46.3
35.66
17.96
39.5
43.4
28
9.5
49.6
54.76
36.86
39.87
Diluted EPS
38.3
46.3
35.66
17.96
39.5
43.4
28
9.5
49.6
54.76
36.86
39.87

Procter & Gamble Health Ltd Annual Profit & Loss

Figures in Rupees Crores

Dec 2016
Dec 2017
Dec 2018
Mar 2020
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Mar 2025
Sales
992.56
698.13
849
1,154.7
1,355.86
1,008.73
1,114.41
1,229.62
1,151.26
934.17
Other Income
24.41
73.94
767.93
58.21
68.89
18.1
13.19
18.39
15.63
10.35
Total Income
1,016.97
772.07
1,616.93
1,212.91
1,424.75
1,026.83
1,127.6
1,248.01
1,166.89
944.52
Expenses
876.98
621.16
700.85
892.39
1,040.45
762.71
846.73
904.94
865.45
615.78
Operating Profit
115.58
76.97
148.15
262.31
315.41
246.02
267.68
324.68
285.81
318.39
Operating Profit Margin %
11.64%
11.03%
17.45%
22.72%
23.26%
24.39%
24.02%
26.4%
24.83%
34.08%
Profit Before Interest, Tax and Depreciation
139.98
150.91
916.08
320.53
384.3
264.12
280.87
343.07
301.44
328.74
Interest
-
-
-
-
-
0.8
0.42
0.77
0.72
0.43
Depreciation
24.81
19.12
21.12
21.4
29.45
30.04
27.08
28.1
27.4
16.69
Profit Before Tax
115.17
131.79
894.96
299.13
354.85
233.28
253.37
314.2
273.32
311.62
Tax Paid
36.05
37.88
56.25
93.91
100.77
56.48
60.85
84.73
72.34
77.21
Profit After Tax
79.13
93.91
838.72
205.22
254.08
176.8
192.52
229.47
200.98
234.41
Total Net profit including share of profit / Loss from associate company
79.13
93.91
838.72
205.22
254.08
176.8
192.52
229.47
200.98
234.41
EPS
47.67
56.57
505.27
123.63
153.1
106.5
115.98
138.23
121.07
141.22
Actual EPS
47.67
56.57
505.27
123.63
153.1
106.5
115.98
138.23
121.07
141.22
Adjusted EPS
47.67
56.57
505.27
123.63
153.1
106.5
115.98
138.23
121.07
141.22
Diluted EPS
47.67
56.57
505.27
123.63
153.1
106.5
115.98
138.23
121.07
141.22

Procter & Gamble Health Ltd Cash Flow

Figures in Rupees Crores

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Mar 2025
Net Cash from Operating Activities
83.47
107.04
53.66
-130.39
235.37
247.26
169.52
236.01
228.29
168.69
Cash Flow from Investing Activities
-67.84
-74.97
-47.63
1,269.72
164.64
-32.27
-25.54
-21.5
-6.87
9.59
Cash Flow from Financing Activities
-11.92
-14.98
-21.98
-30.12
-883.41
-386.63
-288.63
-98.49
-418.11
-234.74
Net Cash Flow
3.71
17.09
-15.95
1,109.21
-483.4
-171.64
-144.65
116.02
-196.69
-56.46

Procter & Gamble Health Ltd Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
DII
12.62%
12.43%
12.31%
12.3%
12.13%
12.67%
13.73%
14.55%
14.84%
14.71%
14.21%
14.16%
FII
0%
0%
0%
0%
0%
7.59%
6.24%
6.4%
6.61%
7.02%
6.87%
6.99%
Public
29.51%
29.42%
29.15%
28.74%
28.49%
27.92%
28.21%
27.23%
26.74%
26.46%
27.11%
27.03%
Total Outstanding Shares
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
Total Shareholders
65,148
63,831
61,030
58,856
57,919
56,730
56,778
55,923
54,792
53,736
53,993
52,478

Mutual Funds that own Procter & Gamble Health Ltd Stock

Check out the Mutual Funds with significant holdings in Procter & Gamble Health Ltd.

Procter & Gamble Health Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Procter & Gamble Health Ltd.

  • Procter & Gamble Health Ltd Earnings Results

    Procter & Gamble Health Ltd’s net profit jumped 294.4% since last year same period to ₹66.18Cr in the Q1 2025-2026. On a quarterly growth basis, Procter & Gamble Health Ltd has generated 8.17% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Procter & Gamble Health Ltd Dividends May,2025

    In the quarter ending March 2025, Procter & Gamble Health Ltd has declared dividend of ₹45.00 per share on 29 May 2025 - translating a dividend yield of 2.90%.

    Read More about Dividends

Indices Featuring Procter & Gamble Health Ltd Stock

Check stock indices that include Procter & Gamble Health Ltd.

S&P BSE 400 MidSmallCap

₹11,668.55

-0.38 (-44.34%)

S&P BSE 250 SmallCap

₹6,616.74

-0.25 (-16.67%)

BSE Healthcare

₹43,622.70

-0.16 (-71.35%)

BSE 500

₹35,287.71

-0.34 (-122.01%)

BSE Small-Cap

₹51,449.23

-0.29 (-150.28%)

Insights on Procter & Gamble Health Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PGHL has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 10.54% to 10.65% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, PGHL stock has moved up by 7.1%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.87% to 6.99% in Jun 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.82% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.6% return, outperforming this stock by 78.2%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 27.11% to 27.03% in Jun 2025 quarter

About Procter & Gamble Health Ltd

Procter and Gamble Health Limited, formerly Merck Limited, is a 51% subsidiary of German firm Merck KGaA and is based in India. It is engaged in the manufacturing and marketing of pharmaceuticals, chemicals, biotechnology products, and consumer health products. The company operates in two divisions: Pharmaceuticals and Chemicals. Pharmaceuticals include Ethicals for treatment of cardiovascular and metabolic diseases, Vitamin-based Formulations, and Consumer Healthcare products. Chemicals division consists of Bulk Drugs and Pigments. It was incorporated in 1967 as E Merck India Ltd and changed its name to Merck Ltd in 2002. In 2018, Merck Life Science Private Limited acquired the Biopharma Performance Materials and Life Science Segments of Merck Ltd for Rs 1,05,200 lakhs. This shifted the company's main focus to manufacturing and marketing pharmaceuticals. The company has expanded its production capacity of Bulk Drugs by 18 tonnes to 479 tonnes, Injection/Nasal Drops by 24 kiloliters to 440 kiloliters, and Tablets/Capsules by 40 million Nos to 400 million Nos. It has launched various products such as Pedimune, Glimepiride, Acrobat and Ziflam, Livogen CZ, Polybion Complete Syrup, Met Neurobion Injection, Evion Forte, Olmighty and Whisper Choice Aloe Vera Tablets, Neurobion Forte, and Livogen Iron and Multivitamin Tonic etc. However, its growth has been affected by the ban on 344 fixed drug combinations, demand notice from National Pharmaceutical Pricing Authority and writ petition filed by Credence Pharmaceuticals Private Limited. The company has challenged the ban and demands and hopes for a positive outcome.

Revenue: ₹338.74Cr as on June 2025 (Q1 FY26)
Net Profit: ₹66.18Cr as on June 2025 (Q1 FY26)
Listing date: 08 Nov, 1994
Chairperson Name: S N Talwar
OrganisationProcter & Gamble Health Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOS N Talwar
E-voting on sharesClick here to vote

FAQs

What is Procter & Gamble Health Ltd share price today?

Procter & Gamble Health Ltd share price today stands at ₹6370 as on at the close of the market. Procter & Gamble Health Ltd share today touched a day high of ₹6739 and a low of ₹6252.5.

What is the 52 week high and 52 week low range for Procter & Gamble Health Ltd share?

Procter & Gamble Health Ltd touched a 52 week high of ₹6739 and a 52 week low of ₹4863. Procter & Gamble Health Ltd share price today i.e. is closed at ₹6370, which is -5.48% down from its 52 week high and 30.99% up from its 52 week low.

What is Procter & Gamble Health Ltd's market capitalisation today?

Procter & Gamble Health Ltd market capitalisation is ₹10,573.81 Cr as on .

How to buy Procter & Gamble Health Ltd shares?

To buy Procter & Gamble Health Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for PGHL or Procter & Gamble Health Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Procter & Gamble Health Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Procter & Gamble Health Ltd trading volume today?

Procter & Gamble Health Ltd trading volume is 67.16K as on . This means that 67.16K shares of Procter & Gamble Health Ltd were bought and sold on the stock market during today's trading session.